Active, not recruitingPhase 3NCT03652064
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
Studying Infantile neuroaxonal dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Janssen Research & Development, LLC
- Principal Investigator
- Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC
- Intervention
- Daratumumab(drug)
- Enrollment
- 395 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2026
Study locations (30)
- Innovative Clinical Research Inc, Cerritos, California, United States
- Baptist MD Anderson, Jacksonville, Florida, United States
- Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, United States
- Norton Healthcare, Louisville, Kentucky, United States
- Tufts Medical Center, Boston, Massachusetts, United States
- Boston University Medical Center, Boston, Massachusetts, United States
- Cancer And Hematology Centers of Western Michigan PC, Grand Rapids, Michigan, United States
- Saint Lukes Hospital Saint Lukes Cancer Specialists, Kansas City, Missouri, United States
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
- San Juan Oncology Associates, Farmington, New Mexico, United States
- Roswell Park Cancer Institute, Buffalo, New York, United States
- NYU Winthrop, Mineola, New York, United States
- Levine Cancer Institute, Charlotte, North Carolina, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Good Samaritan Hospital Corvallis, Corvallis, Oregon, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03652064 on ClinicalTrials.govOther trials for Infantile neuroaxonal dystrophy
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT06964412The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate BrachytherapyBrigham and Women's Hospital
- RECRUITINGNANCT07411300Supporting Caregivers Following Mental Health Emergency Department VisitsAnn & Robert H Lurie Children's Hospital of Chicago
- RECRUITINGNANCT07377877External Oblique Intercostal Block vs Erector Spinae Plane Block for Postoperative Analgesia After Laparoscopic CholecystectomyKarabuk University
- ACTIVE NOT RECRUITINGNANCT06665620Optimizing a Just-in-time Adaptive Intervention for Suicide Safety Planning in AdolescentsKsana Health
- RECRUITINGNANCT06646614Group Advanced Care Planning Pilot for VeteransVA Palo Alto Health Care System
- RECRUITINGNANCT07025954Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand AccretaThe Third Affiliated Hospital of Guangzhou Medical University
- RECRUITINGNANCT07011472Post-Operative Analgesic Selection in Patients Planned for Third Molar Extraction After Undergoing Shared Decision Making Using 2- Versus 3-Option Decision-AidsRutgers, The State University of New Jersey
- RECRUITINGNANCT06933498Effects of Erector Spinae Plane Block on Opioid Consumption, Anesthetic Consumption and Hemodynamics in Lumbar Disc Herniation Surgeries.Ankara Ataturk Sanatorium Training and Research Hospital